Floatz logo

Recombinant Interleukin-11

Chemotherapy-induced Thrombocytopenia

Liaoning Cancer Hospital & InstituteDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Chemotherapy-induced Thrombocytopenia cohort.

Asset / SponsorPhaseRating
Romiplostim
Ain Shams University
Phase 3BB
Herombopag
Institute of Hematology & Blood Diseases Hospital, China
Phase 2CCC
Recombinant Human Interleukin-11 For
Liaoning Cancer Hospital & Institute
D

Same molecule, other indications

Recombinant Interleukin-11 is also rated in:

gestational trophoblastic neoplasmDormant
B
Indicative ·
57 / 100
View asset →
neuroblastomaDormant
B
Indicative ·
57 / 100
View asset →
testicular germ cell tumorDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →